|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.370 USD | +3.01% |
|
+8.73% | -17.47% |
| 07-28 | SNDL Shares Fall After Q2 Swings to Adjusted Operating Loss, Revenue Declines | MT |
| 07-28 | Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 4, 2025. | CI |
| Market Cap | 469M 341M 292M 273M 250M 32.59B 475M 3.23B 1.26B 16.37B 1.28B 1.25B 54.16B | P/E 2026 * |
-22.2x | P/E 2027 * | 189x |
|---|---|---|---|---|---|
| Enterprise Value | 469M 341M 292M 273M 250M 32.59B 475M 3.23B 1.26B 16.37B 1.28B 1.25B 54.16B | EV / Sales 2026 * |
0.52x | EV / Sales 2027 * | 0.51x |
| Free-Float |
95.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SNDL Inc.
| 1 day | +3.01% | ||
| 1 week | +8.73% | ||
| Current month | +11.38% | ||
| 1 month | +6.20% | ||
| 3 months | -6.80% | ||
| 6 months | -13.29% | ||
| Current year | -17.47% |
| 1 week | 1.23 |  | 1.4 |
| 1 month | 1.16 | | 1.4 |
| Current year | 1.16 | | 1.82 |
| 1 year | 1.16 | | 2.89 |
| 3 years | 1.15 | | 2.93 |
| 5 years | 1.15 | | 9.6 |
| 10 years | 1.15 | | 132.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary George
CEO | Chief Executive Officer | 48 | 2020-01-29 |
| Director of Finance/CFO | 53 | 2023-06-30 | |
Phil McBride
CTO | Chief Tech/Sci/R&D Officer | 52 | 2024-11-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Gregory Turnbull
BRD | Director/Board Member | 71 | 2018-09-30 |
Greg Mills
CHM | Chairman | 63 | 2019-05-31 |
Zachary George
BRD | Director/Board Member | 48 | 2019-11-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/31/26 | Tax | Company | 89,500 | 0.0344% | ||
| 7/31/26 | Buy | Chief Executive Officer | 10,000 | 0.0038% | ||
| 7/31/26 | Tax | Company | -582,700 | 0.2239% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.01% | +8.73% | -38.84% | -16.46% | 341M | |
| +0.88% | +6.38% | +76.86% | +128.23% | 1,119B | |
| +1.07% | +3.80% | +51.03% | +61.48% | 651B | |
| +1.20% | +6.21% | +26.47% | +76.45% | 468B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 374B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 302B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 259B | |
| +1.88% | +5.81% | +48.54% | +68.52% | 238B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 208B | |
| +1.87% | +5.61% | +25.81% | +92.42% | 181B | |
| Average | +1.46% | +5.31% | +24.29% | +46.23% | 380.02B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.30% | +72.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 909M 660M 566M 529M 485M 63.19B 921M 6.25B 2.44B 31.74B 2.48B 2.43B 105B | 925M 672M 575M 538M 493M 64.25B 937M 6.36B 2.48B 32.28B 2.52B 2.47B 107B |
| Net income | -21.59M -15.68M -13.43M -12.57M -11.5M -1.5B -21.87M -148M -57.89M -754M -58.87M -57.59M -2.49B | 2.1M 1.52M 1.31M 1.22M 1.12M 146M 2.13M 14.44M 5.63M 73.28M 5.73M 5.6M 242M |
| Net Debt | - | - |
Employees
2,751
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | US$1.370 | +3.01% | 1,835,600 |
| 26-08-20 | US$1.330 | +1.53% | 3,028,385 |
| 26-08-19 | US$1.310 | +6.50% | 1,915,069 |
| 26-08-18 | US$1.230 | 0.00% | 753,311 |
| 26-08-17 | US$1.230 | -2.38% | 1,116,998 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.886CAD
Average target price
4.932CAD
Spread / Average Target
+161.45%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SNDL Stock
Select your edition
All financial news and data tailored to specific country editions
